Studies of taurine in people
86 studies gave taurine to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on fatigue severitymean difference -1.25 (95% CI -3.55 to 1.05); p=0.288 down: Decreases fatigue severity-11.90±4.04 vs -4.57±9.23; Cohen's d -1.02 | Randomized trial12 weeks | 220 peopleUnselected patients with decompensated cirrhosis | Hepatology communications, Apr 24, 2026 |
down: Decreases aspartate aminotransferase down: Lowers the risk of mortalityp < 0.05 down: Decreases hospital staymean difference -3.49 days | Randomized trial30 days | 169 peopleadults | Clinical nutrition ESPEN, Jan 26, 2026 |
up: Increases blood lactateT group peak values higher than P group (P = 0.04) up: Increases tympanic temperatureT group peak values higher than P group (P < 0.01) | Randomized trial | 12 peopleDuring exhaustive exercise under hot and humid conditions | Sports health, Feb 19, 2025 |
up: Improves countermovement jump height43.42 ± 3.46 vs 38.58 ± 3.86 | Randomized trial | 16 people16 male university football players23.69 ± 2.15 yearsMale university football players | Scientific reports, Feb 13, 2025 |
down: Decreases triglycerideWMD -0.56 mg/dL, 95% CI -0.92 to -0.2 down: Decreases fasting insulinWMD -2.15 μU/mL, 95% CI -3.24 to -1.06 down: Decreases HOMA-IRWMD -0.91, 95% CI -1.74 to -0.08 | Review of trialslong-term | adultsIn obese participants (subgroup analysis) | Nutrients, Dec 27, 2024 |
no change: Has no effect on maximal fat oxidationd = -0.07; 0.48 vs 0.49 g/min no change: Has no effect on time to exhaustiond = -0.04; 1,444.8 vs 1,447.6 s no change: Has no effect on VO2peakd = 0.48; 58.9 vs 56.5 ml·kg-1·min-1 | Randomized trial | 11 peopleMenSingle 6 g dose 90 min before incremental running test, versus placebo | International journal of sport nutrition and exercise metabolism, Nov 19, 2024 |
up: Increases breakpoint of compensabilityCohen's d = 0.97 up: Increases whole-body sweat loss up: Increases evaporative heat lossCohen's d = 0.79 | Randomized trial8-days | 15 peopleBoth27 ± 5 years | European journal of applied physiology, Apr 6, 2024 |
no change: Has no effect on mortalityRR 0.70, 95% CI 0.28 to 1.80 no change: Has no effect on ICU length of stay down: Decreases IL-6 | Review of trials | 176 people pooledPatient cohorts | Clinical nutrition ESPEN, Mar 28, 2024 |
up: Improves time to exhaustion down: Decreases blood lactated = 0.8 versus CAF; d = 0.7 versus TAU + CAF | Randomized trial | 12 peopleCycling in heat (35°C, 65% relative humidity) | Sports health, Feb 26, 2024 |
no change: Has no effect on peak power no change: Has no effect on blood lactate | Randomized trialsingle dose 1 h before test | 16 peopleWomen21.3 ± 1.5 yr | Research in sports medicine (Print), Apr 6, 2023 |
| Randomized trialfour times in a 72 h window | 20 peoplemale22.14 ± 1.42 yearsElite male boxer athletes | Nutrients, Oct 20, 2022 | |
down: Decreases delirium9.46% vs 35.36% placebo, P = 0.012 | Randomized trial30 days | 207 peopleolder than 18 yearsAfter liver transplantation, delirium assessed by CAM-ICU | Clinical nutrition (Edinburgh, Scotland), Aug 7, 2022 |
up: Increases superoxide dismutase no change: Has no effect on glutathione reductase up: Increases plasma taurine concentration | Randomized trial16 wk | 24 peopleWomen55 to 70 yearsMidlife adults; Older adults | Nutrition (Burbank, Los Angeles County, Calif.), Apr 22, 2022 |
up: Increases anti-inflammatory interleukins down: Decreases adipocyte size no change: Has no effect on anthropometric characteristics | Randomized trial8 weeks | 16 peopleWomenPatient cohorts | Amino acids, Jul 13, 2021 |
down: Decreases IL-6− 70.75 ± 71.89 vs. -20.09 ± 59.51 up: Improves glasgow Coma Scale down: Decreases weight loss | Randomized trial14 days | 44 peopleover the age of 18 yearsTBI patients, who were admitted to the ICU | Nutrition journal, Jun 8, 2021 |
down: Decreases muscle cramps no change: Has no effect on taurine | Trial4 weeks | 10 people6 patients (60%) were malesmedian 66 years (IQR 58–75)Patients with liver cirrhosis experiencing muscle cramps one or more times per week | Yonsei medical journal, Jan 1, 2021 |
down: Decreases LDL cholesterolp = 0.03 vs control group down: Decreases leptinp = 0. 006 vs control group down: Decreases C-reactive proteinp = 0.03 vs control group | Randomized trial8 weeks | 20 peopleWomenPatient cohorts | Amino acids, Jul 21, 2020 |
down: Decreases fasting blood sugar down: Decreases LDL cholesterol no change: Has no effect on HbA1c | Randomized trial8 weeks | 45 peopleTaurine group versus placebo after 8 weeks | Amino acids, May 29, 2020 |
no change: Has no effect on glycerol | Randomized trialone hour | 17 peoplemale24.8 ± 4.07 yActive male, healthy subjects | Nutrients, May 25, 2020 |
down: Decreases glycated hemoglobin down: Decreases low-density lipoprotein cholesterol down: Decreases pentosidine | Randomized trial8 weeks | 46 peopleTaurine compared with placebo at completion | Canadian journal of diabetes, May 17, 2020 |
up: Increases irisinp < 0.001 at 1 h after exercise, taurine group only | Randomized trial8 weeks | 8 peopleWomen36.6 ± 6.4 yearsTaurine group, 1 h after exercise | Cytokine, Jun 18, 2019 |
no change: Has no effect on oxidative stress and inflammatory parameters up: Improves flow-mediated dilation | Trial4 days | 14 peopleBoth8-35 yearsIn individuals with pretreatment FMD below 10% | Journal of inherited metabolic disease, Apr 11, 2019 |
up: Increases time to exhaustion+10% (25.16 min vs. 22.43 min) up: Increases end-exercise sweat rate+12.7% (687 nL min−1 vs. 600 nL min−1) down: Decreases blood lactate−16.5% (5.75 mmol L−1 vs. 6.85 mmol L−1) | Randomized trial | 11 peopleMenCycling at ventilatory threshold power output in the heat (35°C, 40% RH) | European journal of sport science, Feb 18, 2019 |
up: Increases flow-mediated dilation no change: Has no effect on resistance exercise-induced reduction in flow-mediated dilation | Randomized trial2 weeks | 29 peopleMenAt rest, before exercise | Advances in experimental medicine and biology, Jan 1, 2019 |
up: Improves MMSE-DS total score14.2 to 16.7 points | Trial4 weeks | 16 peopleWomenelderlyOlder adults; taurine supplement group (TG) served with SATL menu | Advances in experimental medicine and biology, Jan 1, 2019 |
up: Increases serum taurine218.0 ± 15.6 μM at 4 weeks, significantly higher than control up: Improves language and executive performance | Randomized trial4 weeks | 31 peopleWomenelderlyOlder adults; Patient cohorts | Advances in experimental medicine and biology, Jan 1, 2019 |
down: Decreases muscle cramp frequencyseven cramps fewer per fortnight vs placebo up: Increases serum taurine no change: Has no effect on adverse side effects | Randomized trial4 weeks per arm | 30 peopleBothmean 54.7 years2 g/d versus placebo in a randomized crossover design | Alimentary pharmacology & therapeutics, Aug 23, 2018 |
down: Decreases stroke-like episodes up: Increases tRNALeu(UUR) taurine modification rate | Trial52 weeks | 10 peoplemean 29.1 years (range 14–46)Patients diagnosed with MELAS | Journal of neurology, neurosurgery, and psychiatry, Apr 17, 2018 |
down: Decreases heart rated = 2.1 up: Improves end-test powerd = 3.7 down: Impairs peak sprint power | Randomized trial | 9 peopleWomenBefore the ramp test, versus placebo | Amino acids, Mar 17, 2018 |
down: Decreases IL-1β/IL-1ra ratio up: Increases neuron-specific enolase | Randomized trial14 weeks | 48 peopleWomen83.58 ± 6.9 yearsOlder adults | Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, Feb 23, 2018 |
down: Decreases isokinetic peak torque-16.1% first; -5.0% best down: Decreases isokinetic power output-17.7% first; -8.0% best up: Improves maximal voluntary muscle power5.2% best power | Randomized trial | 14 peopleMen21.8 ± 2.5 yrIn noncaffeine consumers | Medicine and science in sports and exercise, Feb 1, 2018 |
up: Improves repeated sprint performance up: Improves mean peak powersmall, possible up: Increases intrasprint fatigue indexmoderate, likely | Randomized trial | 7 peopleMenRepeated Wingate cycling | International journal of sports physiology and performance, Dec 28, 2017 |
down: Decreases hepatic venous pressure gradient-12% relative change in HVPG with taurine (20 to 18 mm Hg); between-group P = .0091 absolute, P = .0109 relative no change: Has no effect on systemic haemodynamics | Randomized trial4 weeks | 22 peopleBothmean 52 ± 11 yearsPatient cohorts | Alimentary pharmacology & therapeutics, Nov 3, 2017 |
no change: Has no effect on lactate dehydrogenase no change: Has no effect on inflammatory markers IL-6 and TNF-α | Randomized trial8 weeks | 9 peopleMen25-35 yearsAfter TAU supplementation | The Journal of sports medicine and physical fitness, Jul 25, 2017 |
down: Decreases C-reactive protein down: Decreases Castelli risk index I up: Increases taurine | Randomized trial2 weeks | Before and after incremental exercise in heart failure patients | Therapeutic advances in cardiovascular disease, Jun 5, 2017 |
up: Improves global functioning95% CI 0.3 to 8.8; P = .04 no change: Has no effect on cognitive function95% CI -1.7 to 1.0; P = .582 down: Decreases asthenia, lassitude and fatigabilityP = .006 | Randomized trial12 weeks | 86 people18-25 yearsAdjunctive to low-dose antipsychotic medication | The Journal of clinical psychiatry, Dec 1, 2016 |
| Randomized trial2 weeks | 125 peopleAll of the participants were men18–25 yearsHealthy men | Hypertension research : official journal of the Japanese Society of Hypertension, Jul 14, 2016 | |
no change: Has no effect on physical function no change: Has no effect on lactate | Randomized trialsingle acute dose | 11 peoplemalemean ± SD age 34.6 ± 11.5 yearsMale trained cyclists | Amino acids, Jul 5, 2016 |
down: Decreases delayed increase in carotid-femoral pulse wave velocity after eccentric exercise down: Decreases exercise-induced increase in serum malondialdehyde | Randomized trial14 days before exercise through 3 days after | 29 peopleMenyoungAfter eccentric exercise, taurine vs placebo | Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, Feb 9, 2016 |
down: Decreases blood pressureclinic systolic BP reduction 7.2 mm Hg (taurine) vs 2.6 mm Hg (placebo) up: Improves endothelium-dependent and endothelium-independent vasodilation up: Increases plasma hydrogen sulfide | Randomized trial12 weeks | 120 peopleIn prehypertensive individuals | Hypertension (Dallas, Tex. : 1979), Jan 18, 2016 |